PDE3B Antikörper (AA 1050-2000)
(3 Referenzen)-
- Target Alle PDE3B Antikörper anzeigen
- PDE3B (phosphodiesterase 3B, CGMP-Inhibited (PDE3B))
-
Bindungsspezifität
- AA 1050-2000
-
Reaktivität
- Human, Maus, Ratte, Huhn, Affe
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PDE3B Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunoprecipitation (IP), Immunofluorescence (IF), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Confocal Microscopy (CM)
- Aufreinigung
- Affinity Purified
- Immunogen
- Synthetic peptide taken within amino acid region 1050-2000 on mouse PDE3B protein. Will label all variants of PDE3B.
- Isotyp
- IgG
- Top Product
- Discover our top product PDE3B Primärantikörper
-
anti-phosphodiesterase 3B, CGMP-Inhibited (PDE3B) (AA 400-427) antibody
PDE3B Reaktivität: Human WB, IF, FACS Wirt: Kaninchen Polyclonal RB31670 unconjugated
anti-phosphodiesterase 3B, CGMP-Inhibited (PDE3B) (AA 401-500) antibodyPDE3B Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-phosphodiesterase 3B, CGMP-Inhibited (PDE3B) (AA 401-500) antibodyPDE3B Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 4A4 unconjugated
anti-phosphodiesterase 3B, CGMP-Inhibited (PDE3B) (AA 407-435), (Middle Region) antibodyPDE3B Reaktivität: Human WB, IF, FACS, EIA Wirt: Kaninchen Polyclonal unconjugated
anti-phosphodiesterase 3B, CGMP-Inhibited (PDE3B) (AA 400-660) antibodyPDE3B Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-phosphodiesterase 3B, CGMP-Inhibited (PDE3B) (AA 864-913) antibodyPDE3B Reaktivität: Human, Maus, Ratte, Rind (Kuh), Meerschweinchen WB Wirt: Kaninchen Polyclonal unconjugated
anti-phosphodiesterase 3B, CGMP-Inhibited (PDE3B) antibodyPDE3B Reaktivität: Ratte WB, IP Wirt: Ziege Polyclonal unconjugated
anti-phosphodiesterase 3B, CGMP-Inhibited (PDE3B) antibodyPDE3B Reaktivität: Ratte WB, IP Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.7 μg/μL
-
-
: "Distribution and function of 3',5'-Cyclic-AMP phosphodiesterases in the human ovary." in: Molecular and cellular endocrinology, Vol. 403, pp. 10-20, (2015) (PubMed).
: "Diminished phosphodiesterase-8B potentiates biphasic insulin response to glucose." in: Endocrinology, Vol. 149, Issue 2, pp. 741-8, (2008) (PubMed).
: "Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis." in: Molecular pharmacology, Vol. 67, Issue 1, pp. 263-72, (2005) (PubMed).
-
: "Distribution and function of 3',5'-Cyclic-AMP phosphodiesterases in the human ovary." in: Molecular and cellular endocrinology, Vol. 403, pp. 10-20, (2015) (PubMed).
-
- Target
- PDE3B (phosphodiesterase 3B, CGMP-Inhibited (PDE3B))
- Andere Bezeichnung
- PDE3B (PDE3B Produkte)
- Synonyme
- PDE3B antikoerper, HcGIP1 antikoerper, cGIPDE1 antikoerper, 9830102A01Rik antikoerper, AI847709 antikoerper, phosphodiesterase 3B antikoerper, phosphodiesterase 3B, cGMP-inhibited antikoerper, si:ch211-79e4.4 antikoerper, phosphodiesterase 3B L homeolog antikoerper, PDE3B antikoerper, pde3b antikoerper, Pde3b antikoerper, si:ch211-79e4.4 antikoerper, pde3b.L antikoerper
- UniProt
- Q63085
- Pathways
- Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, cAMP Metabolic Process
-
